Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance. Clin Cancer Res. 2020 02 01; 26(3):608-622.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cell Line, Tumor
Cyclin D1
Drug Resistance, Neoplasm
Female
High-Throughput Nucleotide Sequencing
Humans
Middle Aged
Mutation
Neurofibromin 1
Piperazines
Prospective Studies
Pyridines
Treatment Outcome

authors with profiles

Alexander Pearson